Here is yet another day when an ARK Invest exchange-traded fund run by ETF star Cathie Wood parted with even more Pfizer Inc. (NYSE: PFE) shares. Specifically, the fund sold over 400,000 more shares, as the price of this ETF was flat in the day’s session. However, it is up in the past year.
It was ARK Genomic Revolution ETF (NYSEARCA: ARKG) that shed 407,075 shares of Pfizer. At Thursday’s closing price, this would have valued this sale at roughly $20.4 million. This is only a small fraction of the total holdings. The fund is up about 1.5% over the past 52 weeks.
Check out all the ARK Invest sales for Thursday:
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Sponsored: Find a Qualified Financial Advisor:
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.